Product Information
NORTRIPTYLINE HCL 50 MG CAP is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.2074 per EA under NDC 75907007105. Its NADAC has been published 131 times since Apr 3, 2024.
FDA first approved this application on Mar 30, 1992. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
75907007105
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NORTRIPTYLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA073556FDA Approved
3/30/1992
TE Code
AB
On Market Since
11/17/2023
Pharmacological Classes
Price Statistics
The NADAC for NORTRIPTYLINE HCL 50 MG CAP has been published 131 times since Apr 3, 2024, and over the history we have for it it has risen 69.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2074 per EA |
|---|---|
| All-time high | $0.2316 (Dec 10, 2025) |
| All-time low | $0.0929 (Apr 17, 2024) |
| 52-week high | $0.2316 |
| 52-week low | $0.2022 |
| Median price | $0.2022 |
| Average price | $0.1834 |
| Largest weekly change | +31.7% (Oct 23, 2024) |
| Weeks tracked | 131 |
| Tracking since | Apr 3, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Dr. Reddy's Laboratories Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nortriptyline Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Tricyclic Antidepressant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NORTRIPTYLINE HCL 50 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for NORTRIPTYLINE HCL 50 MG CAP, manufactured by Dr. Reddy's Laboratories Inc., is $0.2074 per EA (NDC 75907007105), effective Sep 30, 2026.
How has the price of NORTRIPTYLINE HCL 50 MG CAP changed over time?
Over the history we have for it, the NADAC for NORTRIPTYLINE HCL 50 MG CAP has risen 69.9%. It has been tracked across 131 weekly CMS publications since Apr 3, 2024.
What are the highest and lowest recorded NADAC prices for NORTRIPTYLINE HCL 50 MG CAP?
Since Apr 3, 2024, the NADAC for NORTRIPTYLINE HCL 50 MG CAP has ranged from a low of $0.0929 (Apr 17, 2024) to a high of $0.2316 (Dec 10, 2025), with a median of $0.2022 per EA.
Are there cheaper alternatives to NORTRIPTYLINE HCL 50 MG CAP?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as NORTRIPTYLINE HCL 50 MG CAP in a comparable dosage form, but none are currently priced below it.
Who manufactures NORTRIPTYLINE HCL 50 MG CAP?
NORTRIPTYLINE HCL 50 MG CAP (NDC 75907007105) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.